Early decision for a left ventricular assist device implantation is necessary for patients with modifier A

Journal of Artificial Organs

Volumn 15, Issue 3, 2012, Pages 301-304

  Imamura, Teruhiko ^a   Kinugawa, Koichiro ^a   Shiga, Taro ^a   Endo, Miyoko ^a   Inaba, Toshiro ^a   Maki, Hisataka ^a   Hatano, Masaru ^a   Imai, Yasushi ^a   Yao, Atsushi ^a   Hirata, Yasunobu ^a   Nishimura, Takashi ^a   Kyo, Shunei ^a   Ono, Minoru ^a   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Heart failure; Implantable cardiac defibrillator; Stage D; Ventricular tachyarrhythmia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BISOPROLOL; CARVEDILOL; DOBUTAMINE; LIDOCAINE; MAGNESOL; SOTALOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CATHETER ABLATION; CONGESTIVE CARDIOMYOPATHY; CRYOABLATION; DEATH; EXTERNAL DEFIBRILLATOR; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; LEFT VENTRICULAR ASSIST DEVICE; MALE; PRIORITY JOURNAL;

FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA; TREATMENT OUTCOME;

EID: 84868377428     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-012-0645-5     Document Type: Article

References (9)

1. Gomes JA, Mehta D, Ip J, Winters SL, Camunas J, Ergin A, Newhouse TT, Pe E. Predictors of long-term survival in patients with malignant ventricular arrhythmias. Am J Cardiol. 1997;15:1054-60.
2. Davis JE, Curtis LA, Rashid H. Idiopathic cardiac electrical storm. J Emerg Med. 2009;37:264-8.
3. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac- resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;20:2140-50.
4. Kinugawa K. How to treat stage D heart failure? When to implant left ventricular assist devices in the era of continuous flow pumps? Circ J. 2011;75:2038-45.
5. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009;28:535-41.
6. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;15:1435-43.
7. Patel P, Williams JG, Brice JH. Sustained ventricular fibrillation in an alert patient: preserved hemodynamics with a left ventricular assist device. Prehosp Emerg Care. 2011;15:533-6.
8. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Third INTERMACS Annual Report: the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30:115-23.
9. Saito S, Matsumiya G, Sakaguchi T, Miyagawa S, Yoshikawa Y, Yamauchi T, Kuratani T, Sawa Y. Risk factor analysis of longterm support with left ventricular assist system. Circ J. 2010;74:715-22.